Secure your spot at ARM’s hybrid 2022 Cell & Gene State of the Industry Briefing, taking place Monday, January 10, 2022. This event is a top-level gathering for 700+ key stakeholders in the field and includes ARM’s annual yearly update on the sector’s progress followed by two panel sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.
This Briefing will be held at the Hilton Union Square in San Francisco, CA and it will also be livestreamed for anyone who wishes to attend virtually. All in-person attendees must provide proof of the COVID-19 vaccination per San Francisco’s health order.
Introduction & Industry Update
8:00am – 8:20am
Janet Lambert, CEO, Alliance for Regenerative Medicine
2022: A Banner Year for Rare Genetic Disease Therapies
8:20am – 9:05am
Next Generation Therapies to Fight Cancer
9:05am – 9:50am
Over 700 of the cell and gene therapy field’s top stakeholders including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.
2021 Cell & Gene State of the Industry Briefing